Patient Square Capital LP Eye Point Pharmaceuticals, Inc. Transaction History
Patient Square Capital LP
- $242 Billion
- Q1 2025
A detailed history of Patient Square Capital LP transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Patient Square Capital LP holds 1,481,977 shares of EYPT stock, worth $13.2 Million. This represents 3.32% of its overall portfolio holdings.
Number of Shares
1,481,977
Previous 1,410,331
5.08%
Holding current value
$13.2 Million
Previous $10.5 Billion
23.55%
% of portfolio
3.32%
Previous 3.93%
Shares
3 transactions
Others Institutions Holding EYPT
# of Institutions
164Shares Held
71.6MCall Options Held
232KPut Options Held
207K-
Cormorant Asset Management, LP Boston, MA8.33MShares$74.2 Million4.79% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$60.6 Million1.61% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.2MShares$55.2 Million0.07% of portfolio
-
Franklin Resources Inc San Mateo, CA4.15MShares$37 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.09MShares$36.4 Million0.05% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $304M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...